Featured Research

from universities, journals, and other organizations

Neuron-generating brain region could hold promise for neurodegenerative therapies

Date:
February 20, 2014
Source:
Cell Press
Summary:
Adult humans continuously produce new neurons in the striatum and these neurons could play an important role in possibly finding new treatments for neurodegenerative disorders, according to a study. To detect the birth of new neurons in the striatum, the authors used a method that measures carbon-14 found in human DNA as a result of above-ground nuclear testing. The discovery may open up new avenues to treat diseases and disorders that affect the striatum.

Adult humans continuously produce new neurons in the striatum, a brain region involved in motor control and cognitive functions, and these neurons could play an important role in recovery from stroke and possibly finding new treatments for neurodegenerative disorders, according to a study published by Cell Press February 20th in the journal Cell. To detect the birth of new neurons in the striatum, the authors used a method that measures carbon-14 found in human DNA as a result of above-ground nuclear testing more than half a century ago.

The findings reveal a surprise finding of new neurons in a human brain structure where they haven't been previously described. The discovery may open up new avenues to treat diseases and disorders that affect the striatum.

"A wide variety of disorders may affect the striatum, including acquired conditions such as stroke and also genetically inherited disorders such as Huntington's disease," says study author Aurélie Ernst of the Karolinska Institute. "We identified a unique pattern of neurogenesis in the adult human brain that might potentially be useful for the development of novel therapies for some of these neurological diseases."

Adult humans and other mammals produce immature neurons in several brain regions, including the lateral ventricle wall. In rodents, new neurons in this brain structure migrate to the olfactory bulb -- a brain region involved in odor perception. But this is not the case in humans, possibly because the sense of smell is less important for us than for other mammals. The fate of new neurons born in the lateral ventricle wall of humans had been a mystery.

Attempting to address this question, Jonas Frisén of the Karolinska Institute and his team used an innovative method for dating the birth of neurons. Their strategy takes advantage of the elevated atmospheric levels of carbon-14, a radioactive form of carbon, caused by above-ground nuclear bomb testing more than 50 years ago. Since the 1963 nuclear test ban treaty, atmospheric levels of carbon-14 have declined at a known rate. When we eat plants or animal products, we absorb carbon-14, and the exact atmospheric concentration at any point in time is stamped into DNA every time a new cell is born.

By measuring the carbon-14 concentration in DNA from the brain tissue of deceased humans, the researchers found that neurogenesis occurs not only in the lateral ventricle wall in adult humans, but also in an adjacent brain region called the striatum. By contrast, neurogenesis in this brain region was significantly reduced in patients who had Huntington's disease, which is characterized by uncontrolled movements and cognitive decline due to the progressive loss of striatal neurons.

"The identification of a subset of neurons that is renewed in the adult human striatum raises the question whether this process can be taken advantage of for therapeutic purposes," Ernst says. "Increasing the generation or promoting the survival of new neurons might offer an attractive possibility in some cases."


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. Aurélie Ernst, Kanar Alkass, Samuel Bernard, Mehran Salehpour, Shira Perl, John Tisdale, Göran Possnert, Henrik Druid, Jonas Frisén. Neurogenesis in the Striatum of the Adult Human Brain. Cell, 2014; DOI: 10.1016/j.cell.2014.01.044

Cite This Page:

Cell Press. "Neuron-generating brain region could hold promise for neurodegenerative therapies." ScienceDaily. ScienceDaily, 20 February 2014. <www.sciencedaily.com/releases/2014/02/140220132154.htm>.
Cell Press. (2014, February 20). Neuron-generating brain region could hold promise for neurodegenerative therapies. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/02/140220132154.htm
Cell Press. "Neuron-generating brain region could hold promise for neurodegenerative therapies." ScienceDaily. www.sciencedaily.com/releases/2014/02/140220132154.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins